Bob Slonim, about whose work on blood donation I talked about here, sent me the following email:
"In our work examining the role of incentives to motivate blood donations, it is remarkable how little (and difficult) it is to have a conversation about, and factor in, the benefits to potential recipients. As Economists, and especially with regards to bone marrow and organ donations, I think it is critical to remain diligent about the benefits in the improvement in the quality of lives, and the lives saved, when incentives (or anything else) can effectively improve supply. If we allow the debate to center solely on the effects to the donors, without any consideration for the recipients, we have a very steep mountain to climb to influence policy, and evidence will continue to take a back seat, indeed may not even get onto the table, compared to other considerations."
It certainly looks that way...
Post a Comment